Skip to content
Press
  • 2 Mar 2026

    AJ Bell Money & Markets: Investment Trust Show: can big dividends make up for weak share price performance? The challenges facing renewable energy and infrastructure trusts.

  • 19 Feb 2026

    Citywire: RTW: We’re in the early innings of a biotech recovery

  • 26 Jan 2026

    Portfolio Adviser: RTW Biotech’s Wong: GLP-1s are tackling the ‘largest pharmaceutical event the industry has ever seen’

  • 26 Jan 2026

    Financial Times: China’s labs pull ahead as global drugmakers invest in biotech pioneers

  • 20 Jan 2026

    Interactive investor: Funds and trusts four pros are buying and selling: Q1 2026

  • 31 Oct 2025

    City AM: City AM’s Rupert Hargreaves spoke with Pieter Staelens, portfolio manager of CVC Income & Growth Limited at the Cadarn Capital Investor Conference

Investor Portal

Exclusive access for professional investors

The Investor Portal provides professional investors with exclusive access to upcoming Cadarn events, detailed fund portfolio insights and associated fund materials. A dedicated information hub that offers an insight into our fund partners’ respective investment approaches, market insights and fund news.

Sign up

Cadarn Capital EU A/S is a tied agent of Acolin Europe AG, authorized and regulated by BaFin.
This is a marketing communication. Please refer to the prospectus of the respective funds and to the KID / KIID before making any final investment decisions. Past performance does not predict future returns.